Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Serum Concentration
100%
Hot Flashes
100%
Tamoxifen Therapy
33%
Treatment Outcome
16%
Body Mass Index
16%
Postmenopausal Women
16%
Endoxifen
16%
Active Metabolite
8%
Serum Samples
8%
Single nucleotide Polymorphism
8%
Between-person
8%
Recurrence Rate
8%
Cytochrome P450 2D6 (CYP2D6)
8%
Treatment Side Effects
8%
Patient-completed
8%
Mortality Rate
8%
Confounding Factors
8%
Estradiol Level
8%
Estradiol
8%
Treatment Optimization
8%
Tamoxifen Metabolites
8%
4-hydroxytamoxifen
8%
Unadjusted Analyses
8%
N-desmethyltamoxifen
8%
Adjuvant Tamoxifen
8%
CYP2D6 Genotype
8%
Oestradiol Concentrations
8%
Biometric Data
8%
Flash Rate
8%
ER+ Breast Cancer
8%
During Treatment
8%
Patient Will
8%
Menopausal Transition
8%
Nursing and Health Professions
Blood Level
100%
Tamoxifen
100%
Hot Flush
100%
Diethylstilbestrol
21%
Body Mass
14%
Treatment Outcome
14%
Endoxifen
14%
CYP2D6
14%
Efficacy
14%
Recurrent Disease
7%
Mortality Rate
7%
Recurrence Risk
7%
Confounding Factor
7%
Afimoxifene
7%
Active Metabolite
7%
Nortamoxifen
7%
Estrogen Receptor Positive Breast Cancer
7%
Side Effect
7%
Nucleotide
7%
Immunology and Microbiology
Blood Level
100%
Metabolite
100%
Body Mass
28%
Postmenopause
28%
Pretreatment
28%
Single Nucleotide Polymorphism
14%
Mortality Rate
14%
Pharmacology, Toxicology and Pharmaceutical Science
Tamoxifen
100%
Hot Flush
100%
Diethylstilbestrol
21%
Endoxifen
14%
CYP2D6
14%
Active Metabolite
7%
Mortality Rate
7%
Recurrent Disease
7%
Estrogen Receptor Positive Breast Cancer
7%
Recurrence Risk
7%
Afimoxifene
7%
Nortamoxifen
7%
Side Effect
7%
Neuroscience
Tamoxifen
100%
Diethylstilbestrol
21%
Body Mass Index
14%
Cytochrome P450 2D6
14%
Single-Nucleotide Polymorphism
7%
Estrogen Receptor
7%
Afimoxifene
7%
Side Effect
7%
Biochemistry, Genetics and Molecular Biology